<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33411236</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>19</Day></DateCompleted><DateRevised><Year>2021</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1559-1182</ISSN><JournalIssue CitedMedium="Internet"><Volume>58</Volume><Issue>5</Issue><PubDate><Year>2021</Year><Month>May</Month></PubDate></JournalIssue><Title>Molecular neurobiology</Title><ISOAbbreviation>Mol Neurobiol</ISOAbbreviation></Journal><ArticleTitle>Neuroprotective Effects of Testosterone in Male Wobbler Mouse, a Model of Amyotrophic Lateral Sclerosis.</ArticleTitle><Pagination><StartPage>2088</StartPage><EndPage>2106</EndPage><MedlinePgn>2088-2106</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12035-020-02209-5</ELocationID><Abstract><AbstractText>Patients suffering of amyotrophic lateral sclerosis (ALS) present motoneuron degeneration leading to muscle atrophy, dysphagia, and dysarthria. The Wobbler mouse, an animal model of ALS, shows a selective loss of motoneurons, astrocytosis, and microgliosis in the spinal cord. The incidence of ALS is greater in men; however, it increases in women after menopause, suggesting a role of sex steroids in ALS. Testosterone is a complex steroid that exerts its effects directly via androgen (AR) or Sigma-1 receptors and indirectly via estrogen receptors (ER) after aromatization into estradiol. Its reduced-metabolite 5&#x3b1;-dihydrotestosterone acts via AR. This study analyzed the effects of testosterone in male symptomatic Wobblers. Controls or Wobblers received empty or testosterone-filled silastic tubes for 2 months. The cervical spinal cord from testosterone-treated Wobblers showed (1) similar androgen levels to untreated control and (2) increased levels of testosterone, and its 5&#x3b1;-reduced metabolites, 5&#x3b1;- dihydrotestosterone, and 3&#x3b2;-androstanediol, but (3) undetectable levels of estradiol compared to untreated Wobblers. Testosterone-treated controls showed comparable steroid concentrations to its untreated counterpart. In testosterone- treated Wobblers a reduction of AR, ER&#x3b1;, and aromatase and high levels of Sigma-1 receptor mRNAs was demonstrated. Testosterone treatment increased ChAT immunoreactivity and the antiinflammatory mediator TGF&#x3b2;, while it lessened vacuolated motoneurons, GFAP+ astrogliosis, the density of IBA1+ microgliosis, proinflammatory mediators, and oxidative/nitrosative stress. Clinically, testosterone treatment in Wobblers slowed the progression of paw atrophy and improved rotarod performance. Collectively, our findings indicate an antiinflammatory and protective effect of testosterone in the degenerating spinal cord. These results coincided with a high concentration of androgen-reduced derivatives after testosterone treatment suggesting that the steroid profile may have a beneficial role on disease progression.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Lara</LastName><ForeName>Agustina</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Laboratory of Neuroendocrine Biochemistry, Instituto de Biologia y Medicina Experimental-CONICET, Obligado 2490, 1428, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Esperante</LastName><ForeName>Iv&#xe1;n</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Laboratory of Neuroendocrine Biochemistry, Instituto de Biologia y Medicina Experimental-CONICET, Obligado 2490, 1428, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meyer</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratory of Neuroendocrine Biochemistry, Instituto de Biologia y Medicina Experimental-CONICET, Obligado 2490, 1428, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liere</LastName><ForeName>Philippe</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-9603-0586</Identifier><AffiliationInfo><Affiliation>U1195 Inserm and University Paris-Sud and University Paris-Saclay, 80 rue du G&#xe9;n&#xe9;ral Leclerc, Le Kremlin-Bic&#xea;tre, 94276, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Giorgio</LastName><ForeName>Noelia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Laboratory of Neuroendocrinology, Instituto de Biologia y Medicina Experimental-CONICET, Obligado 2490, Buenos Aires, 1428, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schumacher</LastName><ForeName>Michael</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-6117-5371</Identifier><AffiliationInfo><Affiliation>U1195 Inserm and University Paris-Sud and University Paris-Saclay, 80 rue du G&#xe9;n&#xe9;ral Leclerc, Le Kremlin-Bic&#xea;tre, 94276, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guennoun</LastName><ForeName>Rachida</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-9219-7300</Identifier><AffiliationInfo><Affiliation>U1195 Inserm and University Paris-Sud and University Paris-Saclay, 80 rue du G&#xe9;n&#xe9;ral Leclerc, Le Kremlin-Bic&#xea;tre, 94276, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gargiulo-Monachelli</LastName><ForeName>Gisella</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Laboratory of Neuroendocrine Biochemistry, Instituto de Biologia y Medicina Experimental-CONICET, Obligado 2490, 1428, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Nicola</LastName><ForeName>Alejandro Federico</ForeName><Initials>AF</Initials><Identifier Source="ORCID">0000-0002-3523-9148</Identifier><AffiliationInfo><Affiliation>Laboratory of Neuroendocrine Biochemistry, Instituto de Biologia y Medicina Experimental-CONICET, Obligado 2490, 1428, Buenos Aires, Argentina.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Human Biochemistry, Faculty of Medicine, University of Buenos Aires, Paraguay 2155, 1121, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonzalez Deniselle</LastName><ForeName>Maria Claudia</ForeName><Initials>MC</Initials><Identifier Source="ORCID">0000-0001-9121-0019</Identifier><AffiliationInfo><Affiliation>Laboratory of Neuroendocrine Biochemistry, Instituto de Biologia y Medicina Experimental-CONICET, Obligado 2490, 1428, Buenos Aires, Argentina. mcgonza@dna.uba.ar.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physiology, Faculty of Medicine, University of Buenos Aires, Paraguay 2155, Buenos Aires, 1121, Argentina. mcgonza@dna.uba.ar.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>11220170100002CO</GrantID><Agency>Consejo Nacional de Investigaciones Cient&#xed;ficas y T&#xe9;cnicas</Agency><Country/></Grant><Grant><GrantID>11220170100301CO</GrantID><Agency>Consejo Nacional de Investigaciones Cient&#xed;ficas y T&#xe9;cnicas</Agency><Country/></Grant><Grant><GrantID>PICT 2017 N&#xba; 1150</GrantID><Agency>Fondo para la Investigaci&#xf3;n Cient&#xed;fica y Tecnol&#xf3;gica</Agency><Country/></Grant><Grant><GrantID>20020170100224BA</GrantID><Agency>Secretaria de Ciencia y Tecnica, Universidad de Buenos Aires</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mol Neurobiol</MedlineTA><NlmUniqueID>8900963</NlmUniqueID><ISSNLinking>0893-7648</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D047628">Estrogen Receptor alpha</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018696">Neuroprotective Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011944">Receptors, Androgen</NameOfSubstance></Chemical><Chemical><RegistryNumber>3XMK78S47O</RegistryNumber><NameOfSubstance UI="D013739">Testosterone</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.14.14.1</RegistryNumber><NameOfSubstance UI="D001141">Aromatase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001141" MajorTopicYN="N">Aromatase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001253" MajorTopicYN="N">Astrocytes</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D047628" MajorTopicYN="N">Estrogen Receptor alpha</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018696" MajorTopicYN="N">Neuroprotective Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011944" MajorTopicYN="N">Receptors, Androgen</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013739" MajorTopicYN="N">Testosterone</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis (ALS)</Keyword><Keyword MajorTopicYN="N">Androgens</Keyword><Keyword MajorTopicYN="N">Inflammation</Keyword><Keyword MajorTopicYN="N">Neuroprotection</Keyword><Keyword MajorTopicYN="N">Neurosteroids</Keyword><Keyword MajorTopicYN="N">Wobbler mouse</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>8</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>11</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>7</Day><Hour>12</Hour><Minute>19</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33411236</ArticleId><ArticleId IdType="doi">10.1007/s12035-020-02209-5</ArticleId><ArticleId IdType="pii">10.1007/s12035-020-02209-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zufiria M, Gil-Bea FJ, Fernandez-Torron R, Poza JJ, Munoz-Blanco JL, Rojas-Garcia R, Riancho J, de Munain AL (2016) ALS: A bucket of genes, environment, metabolism and unknown ingredients. Prog Neurobiol 142:104&#x2013;129. https://doi.org/10.1016/j.pneurobio.2016.05.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2016.05.004</ArticleId><ArticleId IdType="pubmed">27236050</ArticleId></ArticleIdList></Reference><Reference><Citation>Bigini P, Diana V, Barbera S, Fumagalli E, Micotti E, Sitia L, Paladini A, Bisighini C et al (2012) Longitudinal tracking of human fetal cells labeled with super paramagnetic iron oxide nanoparticles in the brain of mice with motor neuron disease. PLoS One 7(2):e32326. https://doi.org/10.1371/journal.pone.0032326</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0032326</ArticleId><ArticleId IdType="pubmed">22384217</ArticleId><ArticleId IdType="pmc">3288077</ArticleId></ArticleIdList></Reference><Reference><Citation>Boillee S, Peschanski M, Junier MP (2003) The wobbler mouse: a neurodegeneration jigsaw puzzle. Mol Neurobiol 28(1):65&#x2013;106. https://doi.org/10.1385/MN:28:1:65</Citation><ArticleIdList><ArticleId IdType="doi">10.1385/MN:28:1:65</ArticleId><ArticleId IdType="pubmed">14514986</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahlke C, Saberi D, Ott B, Brand-Saberi B, Schmitt-John T, Theiss C (2015) Inflammation and neuronal death in the motor cortex of the Wobbler mouse, an ALS animal model. J Neuroinflammation 12:215. https://doi.org/10.1186/s12974-015-0435-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-015-0435-0</ArticleId><ArticleId IdType="pubmed">26597538</ArticleId><ArticleId IdType="pmc">4657283</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez Deniselle MC, Carreras MC, Garay L, Gargiulo-Monachelli G, Meyer M, Poderoso JJ, De Nicola AF (2012) Progesterone prevents mitochondrial dysfunction in the spinal cord of wobbler mice. J Neurochem 122(1):185&#x2013;195. https://doi.org/10.1111/j.1471-4159.2012.07753.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2012.07753.x</ArticleId><ArticleId IdType="pubmed">22486171</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikeda K, Iwasaki Y (2015) Edaravone, a free radical scavenger, delayed symptomatic and pathological progression of motor neuron disease in the Wobbler mouse. PLoS One 10(10):e0140316. https://doi.org/10.1371/journal.pone.0140316</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0140316</ArticleId><ArticleId IdType="pubmed">26469273</ArticleId><ArticleId IdType="pmc">4607459</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JY, Lee JD, Phipps S, Noakes PG, Woodruff TM (2015) Absence of toll-like receptor 4 (TLR4) extends survival in the hSOD1 G93A mouse model of amyotrophic lateral sclerosis. J Neuroinflammation 12:90. https://doi.org/10.1186/s12974-015-0310-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-015-0310-z</ArticleId><ArticleId IdType="pubmed">25962427</ArticleId><ArticleId IdType="pmc">4431460</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratliff WA, Saykally JN, Kane MJ, Citron BA (2018) Neuromuscular junction morphology and gene dysregulation in the Wobbler model of spinal neurodegeneration. J Mol Neurosci 66(1):114&#x2013;120. https://doi.org/10.1007/s12031-018-1153-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-018-1153-8</ArticleId><ArticleId IdType="pubmed">30105628</ArticleId><ArticleId IdType="pmc">6684170</ArticleId></ArticleIdList></Reference><Reference><Citation>Thielsen KD, Moser JM, Schmitt-John T, Jensen MS, Jensen K, Holm MM (2013) The Wobbler mouse model of amyotrophic lateral sclerosis (ALS) displays hippocampal hyperexcitability, and reduced number of interneurons, but no presynaptic vesicle release impairments. PLoS One 8(12):e82767. https://doi.org/10.1371/journal.pone.0082767</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0082767</ArticleId><ArticleId IdType="pubmed">24349357</ArticleId><ArticleId IdType="pmc">3859636</ArticleId></ArticleIdList></Reference><Reference><Citation>Cozzolino M, Carri MT (2012) Mitochondrial dysfunction in ALS. Prog Neurobiol 97(2):54&#x2013;66. https://doi.org/10.1016/j.pneurobio.2011.06.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2011.06.003</ArticleId><ArticleId IdType="pubmed">21827820</ArticleId></ArticleIdList></Reference><Reference><Citation>Hattingen E, Magerkurth J, Pilatus U, Mozer A, Seifried C, Steinmetz H, Zanella F, Hilker R (2009) Phosphorus and proton magnetic resonance spectroscopy demonstrates mitochondrial dysfunction in early and advanced Parkinson&#x2019;s disease. Brain 132(Pt 12):3285&#x2013;3297. https://doi.org/10.1093/brain/awp293</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awp293</ArticleId><ArticleId IdType="pubmed">19952056</ArticleId></ArticleIdList></Reference><Reference><Citation>Johri A, Beal MF (2012) Mitochondrial dysfunction in neurodegenerative diseases. J Pharmacol Exp Ther 342(3):619&#x2013;630. https://doi.org/10.1124/jpet.112.192138</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/jpet.112.192138</ArticleId><ArticleId IdType="pubmed">22700435</ArticleId><ArticleId IdType="pmc">3422529</ArticleId></ArticleIdList></Reference><Reference><Citation>Niedzielska E, Smaga I, Gawlik M, Moniczewski A, Stankowicz P, Pera J, Filip M (2016) Oxidative stress in neurodegenerative diseases. Mol Neurobiol 53(6):4094&#x2013;4125. https://doi.org/10.1007/s12035-015-9337-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-015-9337-5</ArticleId><ArticleId IdType="pubmed">26198567</ArticleId><ArticleId IdType="pmc">26198567</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheng B, Wang X, Su B, Lee HG, Casadesus G, Perry G, Zhu X (2012) Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer&#x2019;s disease. J Neurochem 120(3):419&#x2013;429. https://doi.org/10.1111/j.1471-4159.2011.07581.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2011.07581.x</ArticleId><ArticleId IdType="pubmed">22077634</ArticleId><ArticleId IdType="pmc">22077634</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasco H, Guennoc AM, Veyrat-Durebex C, Gordon PH, Andres CR, Camu W, Corcia P (2012) Amyotrophic lateral sclerosis: a hormonal condition? Amyotroph Lateral Scler 13(6):585&#x2013;588. https://doi.org/10.3109/17482968.2012.706303</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2012.706303</ArticleId><ArticleId IdType="pubmed">22873563</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin S, Al Khleifat A, Al-Chalabi A (2017) What causes amyotrophic lateral sclerosis? F1000Research 6:371. https://doi.org/10.12688/f1000research.10476.1</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.10476.1</ArticleId><ArticleId IdType="pubmed">28408982</ArticleId><ArticleId IdType="pmc">5373425</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrov D, Mansfield C, Moussy A, Hermine O (2017) ALS clinical trials review: 20 years of failure. are we any closer to registering a new treatment? Front Aging Neurosci 9:68. https://doi.org/10.3389/fnagi.2017.00068</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2017.00068</ArticleId><ArticleId IdType="pubmed">28382000</ArticleId><ArticleId IdType="pmc">5360725</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer M, Garay LI, Kruse MS, Lara A, Gargiulo-Monachelli G, Schumacher M, Guennoun R, Coirini H et al (2017) Protective effects of the neurosteroid allopregnanolone in a mouse model of spontaneous motoneuron degeneration. J Steroid Biochem Mol Biol 174:201&#x2013;216. https://doi.org/10.1016/j.jsbmb.2017.09.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsbmb.2017.09.015</ArticleId><ArticleId IdType="pubmed">28951257</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo YE, Ko CP (2012) Dihydrotestosterone ameliorates degeneration in muscle, axons and motoneurons and improves motor function in amyotrophic lateral sclerosis model mice. PLoS One 7(5):e37258. https://doi.org/10.1371/journal.pone.0037258</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0037258</ArticleId><ArticleId IdType="pubmed">22606355</ArticleId><ArticleId IdType="pmc">3351454</ArticleId></ArticleIdList></Reference><Reference><Citation>Giatti S, Boraso M, Melcangi RC, Viviani B (2012) Neuroactive steroids, their metabolites, and neuroinflammation. J Mol Endocrinol 49(3):R125&#x2013;R134. https://doi.org/10.1530/JME-12-0127</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/JME-12-0127</ArticleId><ArticleId IdType="pubmed">22966132</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain R, Ghoumari AM, Bielecki B, Steibel J, Boehm N, Liere P, Macklin WB, Kumar N et al (2013) The neural androgen receptor: a therapeutic target for myelin repair in chronic demyelination. Brain 136(Pt 1):132&#x2013;146. https://doi.org/10.1093/brain/aws284</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aws284</ArticleId><ArticleId IdType="pubmed">23365095</ArticleId><ArticleId IdType="pmc">4572509</ArticleId></ArticleIdList></Reference><Reference><Citation>Sengelaub DR, Xu XM (2018) Protective effects of gonadal hormones on spinal motoneurons following spinal cord injury. Neural Regen Res 13(6):971&#x2013;976. https://doi.org/10.4103/1673-5374.233434</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.233434</ArticleId><ArticleId IdType="pubmed">29926818</ArticleId><ArticleId IdType="pmc">6022470</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan XS, Yang ZJ, Jia JX, Song W, Fang X, Cai ZP, Huo DS, Wang H (2019) Protective mechanism of testosterone on cognitive impairment in a rat model of Alzheimer&#x2019;s disease. Neural Regen Res 14(4):649&#x2013;657. https://doi.org/10.4103/1673-5374.245477</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.245477</ArticleId><ArticleId IdType="pubmed">30632505</ArticleId><ArticleId IdType="pmc">6352583</ArticleId></ArticleIdList></Reference><Reference><Citation>Brocca ME, Garcia-Segura LM (2019) Non-reproductive functions of aromatase in the central nervous system under physiological and pathological conditions. Cell Mol Neurobiol 39(4):473&#x2013;481. https://doi.org/10.1007/s10571-018-0607-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10571-018-0607-4</ArticleId><ArticleId IdType="pubmed">30084008</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghoumari AM, Abi Ghanem C, Asbelaoui N, Schumacher M, Hussain R (2020) Roles of progesterone, testosterone and their nuclear receptors in central nervous system myelination and remyelination. Int J Mol Sci 21(9). https://doi.org/10.3390/ijms21093163</Citation></Reference><Reference><Citation>Jockusch H, Holland A, Staunton L, Schmitt-John T, Heimann P, Dowling P, Ohlendieck K (2014) Pathoproteomics of testicular tissue deficient in the GARP component VPS54: the wobbler mouse model of globozoospermia. Proteomics 14(7-8):839&#x2013;852. https://doi.org/10.1002/pmic.201300189</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmic.201300189</ArticleId><ArticleId IdType="pubmed">24115398</ArticleId></ArticleIdList></Reference><Reference><Citation>Moser JM, Bigini P, Schmitt-John T (2013) The Wobbler mouse, an ALS animal model. Mol Gen Genomics 288(5-6):207&#x2013;229. https://doi.org/10.1007/s00438-013-0741-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00438-013-0741-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmitt-John T (2015) VPS54 and the wobbler mouse. Front Neurosci 9:381. https://doi.org/10.3389/fnins.2015.00381</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2015.00381</ArticleId><ArticleId IdType="pubmed">26539077</ArticleId><ArticleId IdType="pmc">4612502</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez Deniselle MC, Liere P, Pianos A, Meyer M, Aprahamian F, Cambourg A, Di Giorgio NP, Schumacher M et al (2016) Steroid profiling in male Wobbler mouse, a model of amyotrophic lateral sclerosis. Endocrinology 157(11):4446&#x2013;4460. https://doi.org/10.1210/en.2016-1244</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/en.2016-1244</ArticleId><ArticleId IdType="pubmed">27571131</ArticleId></ArticleIdList></Reference><Reference><Citation>Gioria M, Pasini ME, Berruti G (2017) Dynamic of contribution of UBPy-sorted cargo to acrosome biogenesis: effects of its derailment in a mouse model of globozoospermia, the infertile Vps54 (L967Q) mutant. Cell Tissue Res 369(2):413&#x2013;427. https://doi.org/10.1007/s00441-017-2592-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00441-017-2592-1</ArticleId><ArticleId IdType="pubmed">28299521</ArticleId></ArticleIdList></Reference><Reference><Citation>Rathke-Hartlieb S, Schmidt VC, Jockusch H, Schmitt-John T, Bartsch JW (1999) Spatiotemporal progression of neurodegeneration and glia activation in the wobbler neuropathy of the mouse. Neuroreport 10(16):3411&#x2013;3416</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001756-199911080-00028</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer M, Gonzalez Deniselle MC, Garay LI, Monachelli GG, Lima A, Roig P, Guennoun R, Schumacher M et al (2010) Stage dependent effects of progesterone on motoneurons and glial cells of wobbler mouse spinal cord degeneration. Cell Mol Neurobiol 30(1):123&#x2013;135. https://doi.org/10.1007/s10571-009-9437-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10571-009-9437-8</ArticleId><ArticleId IdType="pubmed">19693665</ArticleId></ArticleIdList></Reference><Reference><Citation>Bielecki B, Mattern C, Ghoumari AM, Javaid S, Smietanka K, Abi Ghanem C, Mhaouty-Kodja S, Ghandour MS et al (2016) Unexpected central role of the androgen receptor in the spontaneous regeneration of myelin. Proc Natl Acad Sci U S A 113(51):14829&#x2013;14834. https://doi.org/10.1073/pnas.1614826113</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1614826113</ArticleId><ArticleId IdType="pubmed">27930320</ArticleId><ArticleId IdType="pmc">5187716</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitsumoto H, Ikeda K, Holmlund T, Greene T, Cedarbaum JM, Wong V, Lindsay RM (1994) The effects of ciliary neurotrophic factor on motor dysfunction in wobbler mouse motor neuron disease. Ann Neurol 36(2):142&#x2013;148. https://doi.org/10.1002/ana.410360205</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410360205</ArticleId><ArticleId IdType="pubmed">8053649</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Y, Tan YQ, Leung LK (2017) Exposure to 2,2',4,4'-tetrabromodiphenyl ether at late gestation modulates placental signaling molecules in the mouse model. Chemosphere 181:289&#x2013;295. https://doi.org/10.1016/j.chemosphere.2017.04.089</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chemosphere.2017.04.089</ArticleId><ArticleId IdType="pubmed">28448910</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Giorgio NP, Bizzozzero Hiriart M, Surkin PN, Lopez PV, Bourguignon NS, Dorfman VB, Bettler B, Libertun C et al (2019) Multiple failures in the lutenising hormone surge generating system in GABAB1KO female mice. J Neuroendocrinol 31(8):e12765. https://doi.org/10.1111/jne.12765</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jne.12765</ArticleId><ArticleId IdType="pubmed">31269532</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez Deniselle MC, Garay L, Gonzalez S, Saravia F, Labombarda F, Guennoun R, Schumacher M, De Nicola AF (2007) Progesterone modulates brain-derived neurotrophic factor and choline acetyltransferase in degenerating Wobbler motoneurons. Exp Neurol 203(2):406&#x2013;414. https://doi.org/10.1016/j.expneurol.2006.08.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2006.08.019</ArticleId><ArticleId IdType="pubmed">17052708</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer M, Gonzalez Deniselle MC, Gargiulo-Monachelli G, Garay LI, Schumacher M, Guennoun R, De Nicola AF (2012) Progesterone effects on neuronal brain-derived neurotrophic factor and glial cells during progression of Wobbler mouse neurodegeneration. Neuroscience 201:267&#x2013;279. https://doi.org/10.1016/j.neuroscience.2011.11.034</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2011.11.034</ArticleId><ArticleId IdType="pubmed">22123169</ArticleId></ArticleIdList></Reference><Reference><Citation>Tury A, Tolentino K, Zou Y (2014) Altered expression of atypical PKC and Ryk in the spinal cord of a mouse model of amyotrophic lateral sclerosis. Dev Neurobiol 74(8):839&#x2013;850. https://doi.org/10.1002/dneu.22137</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dneu.22137</ArticleId><ArticleId IdType="pubmed">24123880</ArticleId><ArticleId IdType="pmc">4099310</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres-Platas SG, Comeau S, Rachalski A, Bo GD, Cruceanu C, Turecki G, Giros B, Mechawar N (2014) Morphometric characterization of microglial phenotypes in human cerebral cortex. J Neuroinflammation 11:12. https://doi.org/10.1186/1742-2094-11-12</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-11-12</ArticleId><ArticleId IdType="pubmed">24447857</ArticleId><ArticleId IdType="pmc">3906907</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent SR, Kimura H (1992) Histochemical mapping of nitric oxide synthase in the rat brain. Neuroscience 46(4):755&#x2013;784</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0306-4522(92)90184-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25(4):402&#x2013;408. https://doi.org/10.1006/meth.2001.1262</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/meth.2001.1262</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmisano R, Golfi P, Heimann P, Shaw C, Troakes C, Schmitt-John T, Bartsch JW (2011) Endosomal accumulation of APP in wobbler motor neurons reflects impaired vesicle trafficking: implications for human motor neuron disease. BMC Neurosci 12:24. https://doi.org/10.1186/1471-2202-12-24</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2202-12-24</ArticleId><ArticleId IdType="pubmed">21385376</ArticleId><ArticleId IdType="pmc">3058068</ArticleId></ArticleIdList></Reference><Reference><Citation>Peviani M, Salvaneschi E, Bontempi L, Petese A, Manzo A, Rossi D, Salmona M, Collina S et al (2014) Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation. Neurobiol Dis 62:218&#x2013;232. https://doi.org/10.1016/j.nbd.2013.10.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2013.10.010</ArticleId><ArticleId IdType="pubmed">24141020</ArticleId></ArticleIdList></Reference><Reference><Citation>Piroli GG, Pietranera L, Grillo CA, De Nicola AF (2002) Dehydroepiandrosterone regulation of prolactin gene expression in the anterior pituitary does not depend on galanin induction. Neuro Endocrinol Lett 23(4):321&#x2013;324</Citation><ArticleIdList><ArticleId IdType="pubmed">12195234</ArticleId></ArticleIdList></Reference><Reference><Citation>Ragagnin AMG, Shadfar S, Vidal M, Jamali MS, Atkin JD (2019) Motor neuron susceptibility in ALS/FTD. Front Neurosci 13:532. https://doi.org/10.3389/fnins.2019.00532</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00532</ArticleId><ArticleId IdType="pubmed">31316328</ArticleId><ArticleId IdType="pmc">6610326</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BP, Merry DE, Paulson HL, Lieberman AP, Kolson DL, Fischbeck KH (1998) A cell culture model for androgen effects in motor neurons. J Neurochem 70(3):1054&#x2013;1060. https://doi.org/10.1046/j.1471-4159.1998.70031054.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.1998.70031054.x</ArticleId><ArticleId IdType="pubmed">9489725</ArticleId></ArticleIdList></Reference><Reference><Citation>Oki K, Law TD, Loucks AB, Clark BC (2015) The effects of testosterone and insulin-like growth factor 1 on motor system form and function. Exp Gerontol 64:81&#x2013;86. https://doi.org/10.1016/j.exger.2015.02.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exger.2015.02.005</ArticleId><ArticleId IdType="pubmed">25681641</ArticleId><ArticleId IdType="pmc">4748732</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez Deniselle MC, Gonzalez S, Piroli G, Ferrini M, Lima AE, De Nicola AF (1997) Glucocorticoid receptors and actions in the spinal cord of the Wobbler mouse, a model for neurodegenerative diseases. J Steroid Biochem Mol Biol 60(3-4):205&#x2013;213. https://doi.org/10.1016/s0960-0760(96)00193-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0960-0760(96)00193-8</ArticleId><ArticleId IdType="pubmed">9191978</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez Deniselle MC, Garay L, Lopez-Costa JJ, Gonzalez S, Mougel A, Guennoun R, Schumacher M, De Nicola AF (2004) Progesterone treatment reduces NADPH-diaphorase/nitric oxide synthase in Wobbler mouse motoneuron disease. Brain Res 1014(1-2):71&#x2013;79. https://doi.org/10.1016/j.brainres.2004.04.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2004.04.004</ArticleId><ArticleId IdType="pubmed">15212993</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer M, Gonzalez Deniselle MC, Garay L, Sitruk-Ware R, Guennoun R, Schumacher M, De Nicola AF (2015) The progesterone receptor agonist Nestorone holds back proinflammatory mediators and neuropathology in the wobbler mouse model of motoneuron degeneration. Neuroscience 308:51&#x2013;63. https://doi.org/10.1016/j.neuroscience.2015.09.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2015.09.007</ArticleId><ArticleId IdType="pubmed">26349009</ArticleId></ArticleIdList></Reference><Reference><Citation>Caruso G, Fresta CG, Musso N, Giambirtone M, Grasso M, Spampinato SF, Merlo S, Drago F et al (2019) Carnosine prevents abeta-induced oxidative stress and inflammation in microglial cells: a key role of TGF-beta1. Cells 8(1). https://doi.org/10.3390/cells8010064</Citation></Reference><Reference><Citation>Atallah A, Mhaouty-Kodja S, Grange-Messent V (2017) Chronic depletion of gonadal testosterone leads to blood-brain barrier dysfunction and inflammation in male mice. J Cereb Blood Flow Metab 37(9):3161&#x2013;3175. https://doi.org/10.1177/0271678X16683961</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0271678X16683961</ArticleId><ArticleId IdType="pubmed">28256950</ArticleId></ArticleIdList></Reference><Reference><Citation>Rettew JA, Huet-Hudson YM, Marriott I (2008) Testosterone reduces macrophage expression in the mouse of toll-like receptor 4, a trigger for inflammation and innate immunity. Biol Reprod 78(3):432&#x2013;437. https://doi.org/10.1095/biolreprod.107.063545</Citation><ArticleIdList><ArticleId IdType="doi">10.1095/biolreprod.107.063545</ArticleId></ArticleIdList></Reference><Reference><Citation>Trigunaite A, Dimo J, Jorgensen TN (2015) Suppressive effects of androgens on the immune system. Cell Immunol 294(2):87&#x2013;94. https://doi.org/10.1016/j.cellimm.2015.02.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellimm.2015.02.004</ArticleId><ArticleId IdType="pubmed">25708485</ArticleId></ArticleIdList></Reference><Reference><Citation>Spence RD, Voskuhl RR (2012) Neuroprotective effects of estrogens and androgens in CNS inflammation and neurodegeneration. Front Neuroendocrinol 33(1):105&#x2013;115. https://doi.org/10.1016/j.yfrne.2011.12.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yfrne.2011.12.001</ArticleId><ArticleId IdType="pubmed">22209870</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L, Zhou R, Tong Y, Chen P, Shen Y, Miao S, Liu X (2020) Neuroprotection by dihydrotestosterone in LPS-induced neuroinflammation. Neurobiol Dis 140:104814. https://doi.org/10.1016/j.nbd.2020.104814</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.104814</ArticleId><ArticleId IdType="pubmed">32087283</ArticleId></ArticleIdList></Reference><Reference><Citation>Palaszynski KM, Loo KK, Ashouri JF, Liu HB, Voskuhl RR (2004) Androgens are protective in experimental autoimmune encephalomyelitis: implications for multiple sclerosis. J Neuroimmunol 146(1-2):144&#x2013;152. https://doi.org/10.1016/j.jneuroim.2003.11.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2003.11.004</ArticleId><ArticleId IdType="pubmed">14698857</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu UB, Ruoho AE (2016) Biochemical pharmacology of the Sigma-1 receptor. Mol Pharmacol 89(1):142&#x2013;153. https://doi.org/10.1124/mol.115.101170</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/mol.115.101170</ArticleId><ArticleId IdType="pubmed">26560551</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi T, Su TP (2007) Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival. Cell 131(3):596&#x2013;610. https://doi.org/10.1016/j.cell.2007.08.036</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2007.08.036</ArticleId><ArticleId IdType="pubmed">17981125</ArticleId></ArticleIdList></Reference><Reference><Citation>Collier TL, Waterhouse RN, Kassiou M (2007) Imaging sigma receptors: applications in drug development. Curr Pharm Des 13(1):51&#x2013;72. https://doi.org/10.2174/138161207779313740</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138161207779313740</ArticleId><ArticleId IdType="pubmed">17266588</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas JD, Longen CG, Oyer HM, Chen N, Maher CM, Salvino JM, Kania B, Anderson KN et al (2017) Sigma1 targeting to suppress aberrant androgen receptor signaling in prostate cancer. Cancer Res 77(9):2439&#x2013;2452. https://doi.org/10.1158/0008-5472.CAN-16-1055</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-16-1055</ArticleId><ArticleId IdType="pubmed">28235766</ArticleId><ArticleId IdType="pmc">5462524</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Saif A, Al-Mohanna F, Bohlega S (2011) A mutation in sigma-1 receptor causes juvenile amyotrophic lateral sclerosis. Ann Neurol 70(6):913&#x2013;919. https://doi.org/10.1002/ana.22534</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.22534</ArticleId><ArticleId IdType="pubmed">21842496</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregianin E, Pallafacchina G, Zanin S, Crippa V, Rusmini P, Poletti A, Fang M, Li Z et al (2016) Loss-of-function mutations in the SIGMAR1 gene cause distal hereditary motor neuropathy by impairing ER-mitochondria tethering and Ca2+ signalling. Hum Mol Genet 25(17):3741&#x2013;3753. https://doi.org/10.1093/hmg/ddw220</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddw220</ArticleId><ArticleId IdType="pubmed">27402882</ArticleId></ArticleIdList></Reference><Reference><Citation>Gundlach AL, Largent BL, Snyder SH (1986) Autoradiographic localization of sigma receptor binding sites in guinea pig and rat central nervous system with (+)3H-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine. J Neurosci 6(6):1757&#x2013;1770</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.06-06-01757.1986</ArticleId></ArticleIdList></Reference><Reference><Citation>Horga A, Tomaselli PJ, Gonzalez MA, Laura M, Muntoni F, Manzur AY, Hanna MG, Blake JC et al (2016) SIGMAR1 mutation associated with autosomal recessive Silver-like syndrome. Neurology 87(15):1607&#x2013;1612. https://doi.org/10.1212/WNL.0000000000003212</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000003212</ArticleId><ArticleId IdType="pubmed">27629094</ArticleId><ArticleId IdType="pmc">5067545</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HJ, Kwon MJ, Choi WJ, Oh KW, Oh SI, Ki CS (1957) Kim SH (2014) Mutations in UBQLN2 and SIGMAR1 genes are rare in Korean patients with amyotrophic lateral sclerosis. Neurobiol Aging 35(8):e1957&#x2013;e1958. https://doi.org/10.1016/j.neurobiolaging.2014.03.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.03.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Hu Z, Liu L, Xie Y, Zhan Y, Zi X, Wang J, Wu L et al (2015) A SIGMAR1 splice-site mutation causes distal hereditary motor neuropathy. Neurology 84(24):2430&#x2013;2437. https://doi.org/10.1212/WNL.0000000000001680</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000001680</ArticleId><ArticleId IdType="pubmed">26078401</ArticleId></ArticleIdList></Reference><Reference><Citation>Luty AA, Kwok JB, Dobson-Stone C, Loy CT, Coupland KG, Karlstrom H, Sobow T, Tchorzewska J et al (2010) Sigma nonopioid intracellular receptor 1 mutations cause frontotemporal lobar degeneration-motor neuron disease. Ann Neurol 68(5):639&#x2013;649. https://doi.org/10.1002/ana.22274</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.22274</ArticleId><ArticleId IdType="pubmed">21031579</ArticleId></ArticleIdList></Reference><Reference><Citation>Mavlyutov TA, Epstein ML, Andersen KA, Ziskind-Conhaim L, Ruoho AE (2010) The sigma-1 receptor is enriched in postsynaptic sites of C-terminals in mouse motoneurons. An anatomical and behavioral study. Neuroscience 167(2):247&#x2013;255. https://doi.org/10.1016/j.neuroscience.2010.02.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2010.02.022</ArticleId><ArticleId IdType="pubmed">20167253</ArticleId><ArticleId IdType="pmc">2862368</ArticleId></ArticleIdList></Reference><Reference><Citation>Ullah MI, Ahmad A, Raza SI, Amar A, Ali A, Bhatti A, John P, Mohyuddin A et al (2015) In silico analysis of SIGMAR1 variant (rs4879809) segregating in a consanguineous Pakistani family showing amyotrophic lateral sclerosis without frontotemporal lobar dementia. Neurogenetics 16(4):299&#x2013;306. https://doi.org/10.1007/s10048-015-0453-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10048-015-0453-1</ArticleId><ArticleId IdType="pubmed">26205306</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe S, Ilieva H, Tamada H, Nomura H, Komine O, Endo F, Jin S, Mancias P et al (2016) Mitochondria-associated membrane collapse is a common pathomechanism in SIGMAR1- and SOD1-linked ALS. EMBO Molec Med 8(12):1421&#x2013;1437. https://doi.org/10.15252/emmm.201606403</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201606403</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryskamp DA, Korban S, Zhemkov V, Kraskovskaya N, Bezprozvanny I (2019) Neuronal Sigma-1 receptors: signaling functions and protective roles in neurodegenerative diseases. Front Neurosci 13:862. https://doi.org/10.3389/fnins.2019.00862</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00862</ArticleId><ArticleId IdType="pubmed">31551669</ArticleId><ArticleId IdType="pmc">6736580</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>